NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -99.5% | 200 | -98.4% | 0.00% | -98.9% |
| Q1 2020 | $218,000 | -19.9% | 12,200 | -3.2% | 0.09% | -9.0% |
| Q4 2019 | $272,000 | +13.8% | 12,600 | -3.8% | 0.10% | +20.5% |
| Q3 2019 | $239,000 | -52.4% | 13,100 | -7.1% | 0.08% | -51.5% |
| Q2 2019 | $502,000 | +5.9% | 14,100 | 0.0% | 0.17% | +8.9% |
| Q1 2019 | $474,000 | +20.3% | 14,100 | +17.5% | 0.16% | +15.4% |
| Q4 2018 | $394,000 | -46.2% | 12,000 | 0.0% | 0.14% | -33.7% |
| Q3 2018 | $732,000 | +24.9% | 12,000 | 0.0% | 0.20% | +19.2% |
| Q2 2018 | $586,000 | -54.0% | 12,000 | 0.0% | 0.17% | -53.5% |
| Q1 2018 | $1,275,000 | +77.8% | 12,000 | 0.0% | 0.37% | +86.9% |
| Q4 2017 | $717,000 | +149.0% | 12,000 | 0.0% | 0.20% | +120.0% |
| Q3 2017 | $288,000 | – | 12,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |